Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European …

SD Fossa, PHT Slee, M Brausi, S Horenblas… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: Time to progression (TTP), overall survival, and quality of life (QL) were
compared in patients with hormone-resistant prostate cancer (HRPC) treated with …
被引用次数：239 相关文章

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European …

SD Fosså, PH Slee, M Brausi… - Journal of clinical …, 2001 - pubmed.ncbi.nlm.nih.gov
Purpose Time to progression (TTP), overall survival, and quality of life (QL) were compared
in patients with hormone-resistant prostate cancer (HRPC) treated with prednisone (5 mg …

[引用][C] Flutamide versus prednisone in patients with prostate Cancer symptomatically progressing after androgen-ablative therapy: A phase III study of the European …

SD FOSSA, PH SLEE, M BRAUSI… - Journal of clinical …, 2001 - pascal-francis.inist.fr
Flutamide versus prednisone in patients with prostate Cancer symptomatically progressing
after androgen-ablative therapy : A phase III study of the European Organization for …

Flutamide Versus Prednisone in Patients With Prostate Cancer Symptomatically Progressing After Androgen-Ablative Therapy: A Phase III Study of the European …

SD Fosså, PHT Slee, M Brausi, S Horenblas… - Journal of Clinical …, 2001 - cir.nii.ac.jp
抄録< jats: p> PURPOSE: Time to progression (TTP), overall survival, and quality of life (QL)
were compared in patients with hormone-resistant prostate cancer (HRPC) treated with …

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European …

SD Fosså, PH Slee, M Brausi, S Horenblas… - Journal of Clinical …, 2001 - europepmc.org
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing
after androgen-ablative therapy: a phase III study of the European organization for research …

[引用][C] Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European …

F SD - J Clin Oncol, 2001 - cir.nii.ac.jp
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after
androgen-ablative therapy : a phase III study of the European organization for research and …

[引用][C] Flutamide versus prednisone in patients with prostate Cancer symptomatically progressing after androgen-ablative therapy: A phase III study of the European …

SD FOSSA, PH SLEE… - Journal of …, 2001 - American Society of Clinical …